Cannabinoids

Publication Title: 
Biological Psychiatry

The past decade has witnessed a number of societal and political changes that have raised critical questions about the long-term impact of marijuana (Cannabis sativa) that are especially important given the prevalence of its abuse and that potential long-term effects still largely lack scientific data. Disturbances of the epigenome have generally been hypothesized as the molecular machinery underlying the persistent, often tissue-specific transcriptional and behavioral effects of cannabinoids that have been observed within one's lifetime and even into the subsequent generation.

Author(s): 
Szutorisz, Henrietta
Hurd, Yasmin L.
Publication Title: 
Indian Journal of Experimental Biology
Author(s): 
Ghosh, P.
Bhattacharya, S. K.
Publication Title: 
General Pharmacology
Author(s): 
Hatoum, N. S.
Davis, W. M.
Elsohly, M. A.
Turner, C. E.
Publication Title: 
General Pharmacology

1. Pretreatment with a Cannabis constituent, cannabichromene (CBC), i.p., had no effect on in vitro hepatic microsomal enzyme activity compared to a known inhibitor of these systems, SKF 525-A. 2. The results indicate that the previously reported CBC potentiation of CNS depressant-induced hypnosis is not mediated by the hepatic microsomal enzyme system.

Author(s): 
Kapeghian, J. C.
Jones, A. B.
Murphy, J. C.
Elsohly, M. A.
Turner, C. E.
Publication Title: 
British Journal of Pharmacology

Despite the generally held view that alcohol is an unspecific pharmacological agent, recent molecular pharmacology studies demonstrated that alcohol has only a few known primary targets. These are the NMDA, GABA(A), glycine, 5-hydroxytryptamine 3 (serotonin) and nicotinic ACh receptors as well as L-type Ca(2+) channels and G-protein-activated inwardly rectifying K(+) channels.

Author(s): 
Vengeliene, V.
Bilbao, A.
Molander, A.
Spanagel, R.
Publication Title: 
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)

Smokeable herbal mixtures containing synthetic agonists of cannabinoid receptors, known under brand names such as Spice, K2 and Kronic, represent a relatively new type of designer psychoactive drugs that has recently emerged on the recreational drug market. Although the Spice packages are labelled 'not for human consumption' or 'for aromatherapy only' and declared to be purely herbal, these herbal mixtures produce cannabis-like effects after smoking.

Author(s): 
Zawilska, Jolanta B.
Wojcieszak, Jakub
Publication Title: 
Immunobiology

Cannabinoids are a group of compounds present in Cannabis plant (Cannabis sativa L.). They mediate their physiological and behavioral effects by activating specific cannabinoid receptors. With the recent discovery of the cannabinoid receptors (CB1 and CB2) and the endocannabinoid system, research in this field has expanded exponentially.

Author(s): 
Rieder, Sadiye Amcaoglu
Chauhan, Ashok
Singh, Ugra
Nagarkatti, Mitzi
Nagarkatti, Prakash
Publication Title: 
Vitamins and Hormones

Autoimmune hepatitis is a severe immune mediated chronic liver disease with a prevalence range between 50 and 200 cases per million in Western Europe and North America and mortality rates of up to 80% in untreated patients. The induction of CB1 and CB2 cannabinoid receptors during liver injury and the potential involvement of endocannabinoids in the regulation of this process have sparked significant interest in further evaluating the role of cannabinoid systems during hepatic disease. Cannabinoids have been shown to possess significant immunosuppressive and anti-inflammatory properties.

Author(s): 
Pandey, Rupal
Hegde, Venkatesh L.
Singh, Narendra P.
Hofseth, Lorne
Singh, Uday
Ray, Swapan
Nagarkatti, Mitzi
Nagarkatti, Prakash S.
Publication Title: 
Future Medicinal Chemistry

Cannabinoids are a group of compounds that mediate their effects through cannabinoid receptors. The discovery of Δ9-tetrahydrocannabinol (THC) as the major psychoactive principle in marijuana, as well as the identification of cannabinoid receptors and their endogenous ligands, has led to a significant growth in research aimed at understanding the physiological functions of cannabinoids. Cannabinoid receptors include CB1, which is predominantly expressed in the brain, and CB2, which is primarily found on the cells of the immune system.

Author(s): 
Nagarkatti, Prakash
Pandey, Rupal
Rieder, Sadiye Amcaoglu
Hegde, Venkatesh L.
Nagarkatti, Mitzi
Publication Title: 
Trends in Pharmacological Sciences

Cannabinoids have emerged as powerful drug candidates for the treatment of inflammatory and autoimmune diseases due to their immunosuppressive properties. Significant clinical and experimental data on the use of cannabinoids as anti-inflammatory agents exist in many autoimmune disease settings, but virtually no studies have been undertaken on their potential role in transplant rejection. Here we suggest a theoretical role for the use of cannabinoids in preventing allograft rejection.

Author(s): 
Nagarkatti, Mitzi
Rieder, Sadiye Amcaoglu
Hegde, Venkatesh L.
Kanada, Shunsuke
Nagarkatti, Prakash

Pages

Subscribe to RSS - Cannabinoids